Medicamen Biotech Ltd's board meeting on April 24, 2025, approved the allotment of 8,48,215 equity shares at Rs. 530 each, raising Rs. 44.96 crore, and 6,50,000 convertible warrants for Rs. 34.45 crore, increasing the paid-up capital to Rs. 13.56 crore.